<SEC-DOCUMENT>0001213900-25-044690.txt : 20250516
<SEC-HEADER>0001213900-25-044690.hdr.sgml : 20250516
<ACCEPTANCE-DATETIME>20250516111334
ACCESSION NUMBER:		0001213900-25-044690
CONFORMED SUBMISSION TYPE:	CB
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20250516
DATE AS OF CHANGE:		20250516

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRF S.A.
		CENTRAL INDEX KEY:			0001122491
		STANDARD INDUSTRIAL CLASSIFICATION:	MEAT PACKING PLANTS [2011]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				000000000
		STATE OF INCORPORATION:			D5
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CB
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-81914
		FILM NUMBER:		25957633

	BUSINESS ADDRESS:	
		STREET 1:		AV DAS NACOES UNIDAS 14401 22ND-25TH
		STREET 2:		FLOORS TORRE A2 VILA GERTRUDES 04794-000
		CITY:			SAO PAULO SP BRAZIL
		STATE:			D5
		ZIP:			00000
		BUSINESS PHONE:		551123225377

	MAIL ADDRESS:	
		STREET 1:		AV DAS NACOES UNIDAS 14401 22ND-25TH
		STREET 2:		FLOORS TORRE A2 VILA GERTRUDES 04794-000
		CITY:			SAO PAULO SP BRAZIL
		STATE:			D5
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRF-BRASIL FOODS S.A.
		DATE OF NAME CHANGE:	20090708

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PERDIGAO SA
		DATE OF NAME CHANGE:	20000823

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MARFRIG GLOBAL FOODS S.A.
		CENTRAL INDEX KEY:			0001496919
		ORGANIZATION NAME:           	International Corp Fin
		EIN:				000000000

	FILING VALUES:
		FORM TYPE:		CB

	BUSINESS ADDRESS:	
		STREET 1:		AVENIDA CHEDID JAFET, NO 222
		STREET 2:		BLOCK A, 1ST FLOOR
		CITY:			SAO PAULO
		STATE:			D5
		ZIP:			04551-065
		BUSINESS PHONE:		55 11 3728 8600

	MAIL ADDRESS:	
		STREET 1:		AVENIDA CHEDID JAFET, NO 222
		STREET 2:		BLOCK A, 1ST FLOOR
		CITY:			SAO PAULO
		STATE:			D5
		ZIP:			04551-065

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MARFRIG ALIMENTOS S.A.
		DATE OF NAME CHANGE:	20100716
</SEC-HEADER>
<DOCUMENT>
<TYPE>CB
<SEQUENCE>1
<FILENAME>ea0242433-cb_marfrig.htm
<DESCRIPTION>FORM CB
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form&nbsp;CB</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tender Offer/Rights Offering Notification Form</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Please place an X in the box(es) to designate the
appropriate rule provision(s) relied upon to file this Form:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 96%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities Act Rule 801 (Rights Offering)</FONT></TD>
    <TD STYLE="text-align: center; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities Act Rule 802 (Exchange Offer)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange Act Rule 13e-4(h)(8) (Issuer Tender Offer)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange Act Rule 14d-1(c) (Third Party Tender Offer)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange Act Rule 14e-2(d) (Subject Company Response)</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BRF S.A.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Subject Company)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Not Applicable</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Translation of Subject Company&rsquo;s Name into
English (if applicable))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Federative Republic of Brazil </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Jurisdiction of Subject Company&rsquo;s Incorporation
or Organization)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Marfrig Global Foods S.A. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Person(s) Furnishing Form)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Common Shares and American Depositary Shares,
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>representing common shares of BRF S.A.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Title of Class of Subject Securities)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>10552T107 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(CUSIP Number of Class of Securities
(if applicable))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BRF S.A.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Attn: Fabio Luis Mendes Mariano</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Chief Financial and Investor Relations Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">14401 Av. das Na&ccedil;&otilde;es Unidas, 22nd
Floor,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">S&atilde;o Paulo, 04730 090, Brazil</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">+55 (11) 2322-5377</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, Address (including zip code) and Telephone
Number (including area code) of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Person(s) Authorized to Receive Notices and Communications
on Behalf of Subject Company)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>N/A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Date Tender Offer/Rights Offering Commenced)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART I - INFORMATION SENT TO SECURITY HOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 1. Home Jurisdiction Documents</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">The following document is attached hereto as an exhibit to this
form:</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 9%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Exhibit No.</I></B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 90%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Description</I></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">99.1</P></TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A HREF="ea024243302ex99-1_marfrig.htm">Joint Material Fact <I>(fato relevante)</I> disseminated in Brazil by BRF S.A. (&ldquo;BRF&rdquo;) and Marfrig Global Foods S.A. (&ldquo;Marfrig&rdquo;) on May 15, 2025</A></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Not applicable.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 2. Informational Legends</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Included in document attached hereto as Exhibit
99.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II &ndash; INFORMATION NOT REQUIRED TO
BE SENT TO SECURITY HOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">Not Applicable.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">Not Applicable.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: justify">Not Applicable.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART III - CONSENT TO SERVICE OF PROCESS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">Form F-X filed concurrently with the Securities and Exchange
Commission on the date hereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">Not Applicable.</TD>
</TR></TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART IV - SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">After due inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Marfrig Global Foods S.A.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: May 16, 2025</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Rui Mendon&ccedil;a Junior</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rui Mendon&ccedil;a Junior</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Tang David</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tang David</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea024243302ex99-1_marfrig.htm
<DESCRIPTION>JOINT MATERIAL FACT (FATO RELEVANTE) DISSEMINATED IN BRAZIL BY BRF S.A. ("BRF") AND MARFRIG GLOBAL FOODS S.A. ("MARFRIG") ON MAY 15, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt auto"><B>This business combination involves the securities
of a Brazilian company. The business combination is subject to disclosure requirements of Brazil that are different from those of the
United States. Financial statements included in the document, if any, have been prepared in accordance with foreign accounting
standards that may not be comparable to financial statements of United States companies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt auto">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt auto"><B>It may be difficult for you to enforce your rights
and any claim you may have arising under the U.S. federal securities laws, since the issuer is located in Brazil, and some or all of its
officers and directors may be residents of Brazil. You may not be able to sue a Brazilian company or its officers or directors in a Brazilian
court for violations of the U.S. securities laws. It may be difficult to compel a Brazilian company and its affiliates to subject themselves
to a U.S. court&rsquo;s judgment.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt auto">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt auto; text-align: left"><B>You should be aware that the issuer may purchase securities
otherwise than under the exchange offer, such as in open market or privately negotiated purchases.</B></P>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 51%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><IMG SRC="ex99-1_001.jpg" ALT=""></TD>
    <TD STYLE="width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><IMG SRC="ex99-1_002.jpg" ALT=""></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><B>MARFRIG GLOBAL FOODS S.A.<BR>
</B>Publicly Traded Company<BR>
CNPJ/MF n&ordm; 03.853.896/0001-40<BR>
NIRE 35.300.341.031</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><B>BRF S.A.<BR>
</B>Publicly Traded Company<BR>
CNPJ/MF n&ordm; 01.838.723/0001-27<BR>
NIRE 42.300.034.240</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>JOINT MATERIAL FACT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 11.75pt 0pt 9pt"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>MARFRIG GLOBAL FOODS S.A.</B> (&ldquo;<B>Marfrig</B>&rdquo;)
and <B>BRF S.A.</B> (&ldquo;<B>BRF</B>&rdquo; and, together with Marfrig, the &ldquo;<B>Companies</B>&rdquo;), in compliance with Article
157, Paragraph 4, of Law No. 6,404, dated December 15, 1976 (&ldquo;<B>Brazilian Corporations Law</B>&rdquo;), CVM Resolution No. 44,
dated August 23, 2021 (&ldquo;<B>CVM Resolution 44</B>&rdquo;), and CVM Resolution No. 78, dated March 29, 2022 (&ldquo;<B>CVM Resolution
78</B>&rdquo;), hereby, through this joint material fact, inform their shareholders and the market in general that, on the present date,
the  Plan of Merger of BRF S.A. Shares by Marfrig Global Foods S.A.&rdquo; (&ldquo;<B>Plan of Merger</B>&rdquo;) was executed,
which sets forth the terms and conditions applicable to the Merger (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">In addition to the execution of the Plan of
Merger, at meetings held on the date hereof, (i) the Board of Directors of Marfrig (&ldquo;<B>Marfrig Board</B>&rdquo;) approved the
convening of Marfrig&rsquo;s extraordinary general meeting, to be held on the first call on June 18, 2025, at 11:00 a.m. S&atilde;o
Paulo, Brazil time (&ldquo;<B>Marfrig EGM</B>&rdquo;); and (ii) the Board of Directors of BRF (&ldquo;<B>BRF Board</B>&rdquo;)
approved the convening of BRF&rsquo;s extraordinary general meeting, to be held on the first call on June 18, 2025, at 9:00 a.m.
S&atilde;o Paulo, Brazil time (&ldquo;<B>BRF EGM</B>&rdquo; and, together with the Marfrig EGM, the &ldquo;<B>EGMs</B>&rdquo;),
which will deliberate on the Merger. The information and documents related to the convening of the EGMs, including the management
proposal and the Plan of Merger, will be duly and timely disclosed by the Companies, in accordance with the terms and
deadlines of applicable legislation and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Pursuant to the provisions of CVM Resolution 78,
the main terms and conditions of the Merger are described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">1</TD><TD STYLE="text-align: left">Identification of the companies involved in the transaction and a brief description of the activities
they undertake</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>1.1</B></FONT></TD><TD STYLE="text-align: left"><U>Marfrig Global Foods S.A.</U>
                                            Marfrig is a publicly traded company, registered as category &ldquo;A&rdquo; issuer of securities
                                            with the Brazilian Securities and Exchange Commission (&ldquo;<B>CVM</B>&rdquo;) and listed
                                            on B3 S.A. &ndash; Brasil, Bolsa, Balc&atilde;o (&ldquo;<B>B3</B>&rdquo;), and admitted for
                                            trading on the &ldquo;<I>Novo Mercado</I>&rdquo; B3 segment (&ldquo;<B>Novo Mercado</B>&rdquo;),
                                            with its registered office located in the city of S&atilde;o Paulo, State of S&atilde;o Paulo,
                                            at Avenida Queiroz Filho, No. 1,560, Block 5 (Sabi&aacute; Tower), 3rd floor, Room 301, Vila
                                            Hamburguesa, ZIP Code 05319-000, registered with the National Registry of Legal Entities
                                            of the Ministry of Finance (&ldquo;<B>CNPJ/MF</B>&rdquo;) under No. 03.853.896/0001-40. Marfrig&rsquo;s
                                            corporate purpose includes the following activities: (i) operation of slaughterhouses, including
                                            the slaughtering of cattle, horses, pigs, goats, sheep, poultry, and buffalo, and the industrialization
                                            and commercialization of animal products and by-products, edible or otherwise, including,
                                            but not limited to, the industrialization and commercialization of leather products and by-products,
                                            in its own or third-party establishments; (ii) purchase, sale, distribution, representation,
                                            import, and export of food products in general, including alcoholic and non-alcoholic beverages
                                            and others; (iii) purchase and sale of live cattle, horses, pigs, goats, sheep, poultry,
                                            and buffalo; (iv) provision of actual labor to other companies; (v) engagement in agricultural,
                                            livestock, and forestry activities; (vi) participation as a partner or shareholder in any
                                            commercial or civil company; (vii) distribution and commercialization of food products in
                                            general; (viii) production, distribution, and commercialization of soaps, washing preparations,
                                            disinfectants, fabric softeners, and other hygiene and cleaning products; (ix) cogeneration,
                                            production, and commercialization of energy and biodiesel; (x) participation in the financial
                                            market, as well as in the carbon credit market; (xi) commercialization and production of
                                            products derived from legumes and vegetables, including all their derivatives and substitutes,
                                            feed, preserves, canned goods, and fats; (xii) transportation of its products and third-party
                                            products; representation and other related ventures necessary for the corporate purposes;
                                            (xiii) breeding, rearing, and fattening of live cattle, horses, pigs, goats, sheep, poultry,
                                            and buffalo in its own and third-party establishments; (xiv) import and export of products
                                            related to the agricultural and livestock activities, including embryos and others; (xv)
                                            provision of actual labor to other companies; (xvi) provision of services to third parties
                                            for the breeding, care, management, fattening, and transportation of live cattle, horses,
                                            pigs, goats, sheep, poultry, and buffalo; (xvii) technical tests and analyses; (xviii) production
                                            of pharmaceutical and chemical products of animal origin; (xix) production of unspecified
                                            organic chemical products; and (xx) ecological restoration services.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>1.2</B></FONT></TD><TD STYLE="text-align: left"><U>BRF S.A.</U> BRF is a publicly traded company, registered as category &ldquo;A&rdquo; issuer of
                                                                             securities with the CVM, listed on B3, and admitted for trading on the Novo Mercado, with its registered office located in the city
                                                                             of Itaja&iacute;, State of Santa Catarina, at Rua Jorge Tzachel, 475, Fazenda Neighborhood, ZIP Code 88301-600, registered with the
                                                                             CNPJ/MF under No. 01.838.723/0001-27. BRF&rsquo;s corporate purpose includes the following activities: (i) industrialization, retail
                                                                             and wholesale commercialization, and exploitation of food products in general, primarily those derived from animal protein and food
                                                                             products that use the cold chain as a support and distribution method; (ii) industrialization and commercialization of animal feed,
                                                                             nutrients, and food supplements; (iii) provision of food services in general; (iv) industrialization, refining, and
                                                                             commercialization of vegetable oils, fats, and dairy products; (v) engagement, conservation, storage, ensiling, and
                                                                             commercialization of grains, their derivatives, and by-products; (vi) retail and wholesale commercialization of consumption and
                                                                             production goods, including commercialization of equipment and vehicles for the development of its logistical activity;
                                                                             (vii)&nbsp;export and import of production and consumption goods; (viii)&nbsp;provision of services of transportation, logistics and
                                                                             distribution of cargo and food products in general; (ix)&nbsp;participation as a partner or shareholder in other companies, aiming
                                                                             at the broadest fulfillment of its corporate purpose; (x)&nbsp;participation in projects necessary to the operation of the its
                                                                             business; (xi)&nbsp;industrialization, on its own or by third-party establishments, commercialization, export and import of
                                                                             pharmaceutical and chemical products of animal origin; (xii)&nbsp;production and commercialization of organic chemical products of
                                                                             animal origin; (xiii)&nbsp;production, distribution and export of pharmaceutical inputs of animal origin; (xiv) intermediation and
                                                                             agency of services and businesses in general, except for real estate; (xv) provision of administrative services to third parties;
                                                                             and (xvi) provision of laboratory analysis and technical services to third parties.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">2</TD><TD STYLE="text-align: left">Description and purpose of the transaction</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left">The transaction set forth in the Plan of
Merger consists of the acquisition by Marfrig of all BRF shares (other than shares held by Marfrig) on the Closing Date, in exchange
for the issuance to BRF shareholders (except Marfrig) of common shares of Marfrig, in accordance with the Exchange Ratio (as defined
below), resulting in the transfer of BRF&rsquo;s shareholder base to Marfrig (&ldquo;<B>Merger</B>&rdquo;). Upon the completion of the
Merger, BRF will become a wholly-owned subsidiary of Marfrig.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">3</TD><TD STYLE="text-align: justify">Main benefits, costs and risks of the transaction</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>3.1</B></FONT></TD><TD STYLE="text-align: left"><U>Benefits</U>. The Merger aims to create a global food company based on a multiprotein
platform, with a strong presence in both domestic and international markets, portfolio diversification, scale, efficiency, and sustainability,
providing significant benefits to both Companies, their shareholders, customers, suppliers, employees, and other stakeholders, generating
operational, financial, and strategic synergies.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left">Additionally, the Companies believe that
the Merger allows for the simplification and optimization of the administrative and corporate structure of the economic group
to which they belong, eliminating or reducing redundant costs, and improving or facilitating access to the capital necessary for the development
of their business plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">In this regard, the Companies believe
that the Merger will have significant strategic value added, driving global consolidation of their businesses and strengthening
their brands through a robust multi-protein platform, including, among others, (i) solidifying their position as leaders in the
global food market; (ii) strategic expansion into new markets, maximizing growth opportunities and commercial synergies, including cross-selling
initiatives; and (iii) increasing the scale and diversification of their operations, enhancing resilience and mitigating risks associated
with sector seasonality and macroeconomic variables.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">The Companies have identified potential
synergies in the context of the Merger. These synergies include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68pt; text-align: justify; text-indent: -34pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman">&#9679;</FONT></TD><TD STYLE="text-align: left">an increase in revenues and a reduction in costs estimated of R$485 million per year, resulting from the
acceleration of cross-selling opportunities, including volumes and other commercial fronts through logistical capillarity and brand strength,
and supply chain synergies (raw materials, packaging, and inputs);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68pt; text-align: left; text-indent: -34pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman">&#9679;</FONT></TD><TD STYLE="text-align: left">a reduction in expenses estimated of R$320 million per year, resulting from the commercial and logistics
structure, the consolidation of a single operational system, and the optimization of the corporate structure; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68pt; text-align: left; text-indent: -34pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.5in"></TD><TD STYLE="text-align: left; width: 0.5in"><FONT STYLE="font-family: Times New Roman">&#9679;</FONT></TD><TD STYLE="text-align: left">resulting fiscal optimization estimated of R$3 billion, net present value.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>3.2</B></FONT></TD><TD STYLE="text-align: left"><U>Costs</U>. It is estimated that the total costs of the Merger will be approximately R$
24 million, including expenses for publications, auditors, appraisers, legal and financial advisors, and other professionals retained to
assist in the Merger, not including any potential outlays incurred to obtain any third-party approvals required for the implementation
of the Merger.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>3.3</B></FONT></TD><TD STYLE="text-align: justify"><U>Risks</U></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left">The management of the Companies does
not foresee any material risks for the implementation of the Merger beyond those typically associated with the Companies&rsquo;
daily activities and consistent with their size and operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left">However, it is noted that the market
value of the shares issued by Marfrig and BRF remains subject to market fluctuations through the Closing Date and, in the case of Marfrig
shares, also after the completion of the Merger, due to a series of factors outside the control of the Companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left">Moreover, the success of the Merger
will depend, in part, on the group&rsquo;s ability to reduce expenses and optimize processes as a result of the simplification of its corporate
structure and consolidation of its businesses. However, there is no certainty that such cost reductions and process optimizations will
be successful. If these objectives are not achieved successfully, the expected benefits from the Merger may not fully materialize
or may take longer than anticipated to be realized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left">The materialization of any of the above
risks or the partial or total failure of the growth opportunities and synergies mapped out within the scope of the Merger
could adversely impact the economic and financial situation, operational results, and the trading price of the securities issued by the
Companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">4</TD><TD STYLE="text-align: justify">Exchange Ratio for Shares</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left">As a result of the Merger,
BRF shareholders (except Marfrig) will receive 0.8521 common shares of Marfrig for each 1 (one) common share of BRF held on the Closing
Date, in accordance with the terms of the Plan of Merger (&ldquo;<B>Closing Date</B>&rdquo; and &ldquo;<B>Exchange Ratio</B>,&rdquo; respectively).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left">The negotiation and determination of
the Exchange Ratio took into account the distribution of dividends and/or interest on own capital in the gross amount of (i) R$3,520,000,000.00
(three billion, five hundred and twenty million reais) by BRF; and (ii) R$2,500,000,000.00 (two billion, five hundred million reais) by
Marfrig, in both cases, to be authorized following the payment of the right of withdrawal of any Dissenting Shareholders (as defined below)
and up to and including the Closing Date (collectively, &ldquo;<B>Permitted Distributions</B>&rdquo;). Accordingly, any Dissenting Shareholders
who exercise their right of withdrawal shall not be entitled to receive the Permitted Distributions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left">The Exchange Ratio shall be adjusted
exclusively (i) in the event of stock splits, consolidations, or in-kind dividend payments of either Company; and/or (ii) according
to the methodology set forth in Annex 3.1.5. of the Plan of Merger. In accordance with the methodology described in Annex 3.1.5 of
the Plan of Merger, any payments made by the Companies upon exercising the right of withdrawal will proportionally reduce the
Permitted Distributions by an equivalent amount applied to both Companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left">The replacement of the shares issued
by BRF underlying the American Depositary Shares representing common shares issued by BRF within the scope of the Merger
will be carried out in accordance with the terms of the respective deposit agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34.05pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34.05pt; text-align: left">Any fractional common shares of
Marfrig resulting from the Merger will be aggregated into whole numbers and subsequently sold on the B3 spot market after
the completion of the Merger, in accordance with a communication to be timely disclosed to the market by Marfrig. The proceeds
from such sales will be made available, net of fees, to the former BRF shareholders who are entitled to the respective fractions, proportionally
to their participation in each share sold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left">Marfrig will not issue shares in connection
with the Merger corresponding to any BRF shares that may be held in treasury, which will be canceled by BRF up to the Closing
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">5</TD><TD STYLE="text-align: justify">Criteria for Determining the Exchange Ratio</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left; text-indent: 0in"><FONT STYLE="font-weight: normal">Considering
that the Merger is a transaction involving the controlling company, Marfrig, and the controlled company, BRF, in compliance
with CVM Guidance Opinion No. 35, of September 1, 2008, the BRF Board established a special independent committee of BRF (&ldquo;</FONT>BRF
Independent Committee<FONT STYLE="font-weight: normal">&rdquo;), whose function was to negotiate the Exchange Ratio and other terms and
conditions of the transaction involving the Companies and submit its recommendation to the BRF Board. The BRF Independent Committee was
advised by Citigroup as its financial advisor, and a fairness opinion was issued by Citigroup Global Markets Inc. in connection with the
Merger.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left; text-indent: 0in"><FONT STYLE="font-weight: normal">In
addition, the Marfrig Board established a special independent committee of Marfrig (&ldquo;</FONT>Marfrig Independent Committee<FONT STYLE="font-weight: normal">&rdquo;
and, together with the BRF Independent Committee, &ldquo;</FONT>Independent Committees<FONT STYLE="font-weight: normal">&rdquo;), which
was responsible for the initial proposal and subsequent negotiation of the Exchange Ratio with the BRF Independent Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left">In this regard, the Exchange Ratio was
exhaustively negotiated between the Independent Committees, taking into account the fair value of the Companies, as well as the assumptions
described in the Plan of Merger, and their recommendation was approved by both Independent Committees in a meeting held on May 15, 2025.
In issuing their favorable recommendation for the transaction, the Independent Committees considered, with the assistance of their external
advisors, a variety of factors, such that the Exchange Ratio was not determined based on a single criterion, but on a combination of various
criteria.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">6</TD><TD STYLE="text-align: justify">Main active and passive elements that will form each portion of the assets, in case of a spin-off.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">Not applicable, given that the Merger does not involve a spin-off.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">7</TD><TD STYLE="text-align: justify">Whether the transaction has been or will be submitted for approval to Brazilian or foreign authorities</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">8</TD><TD STYLE="text-align: left">In operations involving controlling, controlled, or commonly controlled companies, the share exchange
ratio calculated in accordance with Article 264 of Law No. 6,404/1976</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left; text-indent: 0in">Pursuant to Article
264 of the Brazilian Corporations Law, an appraisal report was prepared containing the calculation of the Exchange Ratio of the shares
held by the non-controlling shareholders of BRF, based on the market value of the shareholders&rsquo; equity of Marfrig and BRF, evaluated
in accordance to the same criteria and as of December 31, 2024, at market prices (&ldquo;<B>Article 264 Appraisal Report</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left; text-indent: 0in">If the exchange ratio
resulting from the Merger were calculated based on the Article 264 Appraisal Report, 2.26148341591578 common shares of
Marfrig would be delivered for each 1 (one) common share of BRF held by the shareholders of BRF (excluding Marfrig).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">9</TD><TD STYLE="text-align: justify">Applicability of the right of withdrawal and the value of the refund</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left">Pursuant to Articles 137 and 252, paragraph 2, of the Brazilian Corporations
Law, the Merger, if approved, will entitle the Companies&rsquo; shareholders to exercise a right of withdrawal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left">The right of withdrawal will be guaranteed to the shareholders of each
of the Companies who (i) are holders of shares issued by Marfrig or BRF, as the case may be, uninterruptedly from the date of disclosure
of this joint material fact (inclusive) through the Closing Date; (ii) do not vote in favor of the Merger, abstain from voting, or do
not attend the Marfrig EGM or the BRF EGM, as the case may be; and (iii) expressly manifest their intention to exercise the right of withdrawal
within 30 (thirty) days from the date of publication of the minutes of the Marfrig EGM or the BRF EGM, as the case may be (&ldquo;<B>Dissenting
Shareholders</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>9.1</B></FONT></TD><TD STYLE="text-align: left"><U>Dissenting Shareholders of Marfrig</U>. Pursuant to the Brazilian Corporations Law, the Dissenting
Shareholders of Marfrig will be entitled to the right of withdrawal at the value of the shareholders&rsquo; equity per share of Marfrig,
as approved by the Marfrig ordinary general meeting held on March 31, 2025, which corresponds to R$3.32 (three <I>reais</I> and thirty-two
cents) per share, without prejudice to the right to request a special balance sheet, in accordance with Article 45 of the Brazilian Corporations
Law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B></B></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>9.2</B></FONT></TD><TD STYLE="text-align: left"><U>Dissenting Shareholders of BRF</U>. Pursuant to the Brazilian Corporations Law, the Dissenting Shareholders
of BRF shall be entitled to the right of withdrawal at the value of the shareholders&rsquo; equity per share of BRF as of December 31,
2024, as approved by the BRF ordinary general meeting held on March 31, 2025, which corresponds to R$9.43 (nine <I>reais</I> and forty-three
cents) per share, without prejudice to the right to request a special balance sheet, in accordance with Article 45 of the Brazilian Corporations
Law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left; text-indent: 0in">As described in item
8 above, it is observed that the exchange ratio calculated based on the Article 264 Appraisal Report is more advantageous to the shareholders
of BRF when compared to the Exchange Ratio.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: left; text-indent: 0in">Therefore, the provisions
of Article 264, paragraph 3, of the Brazilian Corporations Law will apply and the Dissenting Shareholders of BRF may opt between (i) the
reimbursement value fixed in accordance with Article 45 of the Brazilian Corporations Law, that corresponds to R$9.43 (nine <I>reais</I>
and forty-three cents) per share, as mentioned above; or (ii) the shareholders&rsquo; equity per share of BRF, determined based on the
Article 264 Appraisal Report, which corresponds to R$19.89 (nineteen <I>reais</I> and eighty-nine cents.) per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>9.3</B></FONT></TD><TD STYLE="text-align: left"><U>Reconsideration</U>. The Companies reserve the right to convene general meetings of the
Companies to ratify or reconsider the Merger, if they determine that the payments in connection with shareholder withdrawal rights to
the Dissenting Shareholders who exercised such rights would jeopardize the financial stability of any of the Companies, in accordance
with Article 137, paragraph 3, of the Brazilian Corporations Law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">10</TD><TD STYLE="text-align: justify">Other relevant information</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>10.1</B></FONT></TD><TD STYLE="text-align: left"><U>Corporate approvals</U>. The completion of the Merger, which will also be subject to the satisfaction
of the Condition Precedent (as defined below) and the occurrence of the Closing Date, will depend on the performance of the following
acts, all of which are interdependent and must be coordinated to occur on the same date:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68pt; text-align: justify; text-indent: -34pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34.1pt"></TD><TD STYLE="width: 33.95pt">(i)</TD><TD STYLE="text-align: left">BRF EGM to, in this order, (a) approve the Plan of Merger; (b) approve the Merger; (c) ratify the
                                                                  appointment of the appraiser responsible for preparing the appraisal report of the market value of the BRF shares to be
                                                                  incorporated by Marfrig (&ldquo;<B>Merger  Appraisal Report</B>&rdquo;) and the Article 264 Appraisal Report; (d)
                                                                  approve the Merger Appraisal Report; (e) approve the Article 264 Appraisal Report; and (f) authorize BRF&rsquo;s management to perform all acts necessary for the completion of the Merger, including, without limitation, the
                                                                  subscription of the common shares to be issued by Marfrig on behalf of the BRF shareholders (other than Marfrig) on the Closing
                                                                  Date, in accordance with Article 252, paragraph 2, of the Brazilian Corporations Law; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 68pt; text-align: justify; text-indent: -34pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 34.1pt"></TD><TD STYLE="width: 33.95pt">(ii)</TD><TD STYLE="text-align: left">Marfrig EGM to, in this order, (a) approve the Plan of Merger; (b) approve the Merger; (c)
approve the increase in the share capital of Marfrig, the respective issuance of common shares by Marfrig, as well as the consequent
amendment and consolidation of Marfrig&rsquo;s bylaws, with delegation to Marfrig Board of the powers to confirm the actual number of shares
to be issued by Marfrig, in the event of adjustments to the Exchange Ratio; (d) ratify the appointment of the valuation company responsible
for the preparation of the Merger Appraisal Report; (e) approve the Merger Appraisal Report; (f) approve Appraisal
Report 264; and (g) authorize Marfrig&rsquo;s management to perform all acts necessary for the completion of the Merger.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>10.2</B></FONT></TD><TD STYLE="text-align: left"><U>Condition Precedent</U>. From the date of execution of the Plan of Merger through the Closing Date
                                                                              (inclusive), there shall be no occurrence of war, armed conflicts, natural disasters and/or other events (e.g. health emergencies;
                                                                              fires in manufacturing units) that adversely and materially impact the productive capacity and/or commercialization (including
                                                                              export) of either Company (&ldquo;<B>Condition</B>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B></B></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>10.3</B></FONT></TD><TD STYLE="text-align: left"><U>Closing</U>. Once the Merger is approved by the EGMs, the Companies and their respective
management shall perform all acts and measures necessary for the implementation of the Merger, including, without limitation,
the confirmation of the occurrence or the waiver of the Condition, as applicable, and the Companies shall disclose the Closing Date to
the market in accordance with applicable legislation and regulations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>10.4</B></FONT></TD><TD STYLE="text-align: left"><U>Change of Corporate Name</U>. Additionally, Marfrig informs that it has submitted to the Marfrig EGM
the proposal to approve the change of Marfrig&rsquo;s corporate name from &ldquo;Marfrig Global Foods S.A.&rdquo; to &ldquo;<B STYLE="font-style: normal; font-weight: normal">MBRF Global Foods
Company S.A.</B>,&rdquo; subject to the consummation of the Merger.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>10.5</B></FONT></TD><TD STYLE="text-align: left"><U>Additional Information</U>. In compliance with the provisions of Article 3 of CVM Resolution 78 and
the provisions of CVM Resolution No. 81, of March 29, 2022, the documents related to the Merger and the EGMs are or will
be, as applicable, available to the shareholders of each of the Companies at the registered office of each of the Companies, as well as
on the websites of Marfrig (ri.marfrig.com.br) or BRF (ri.brf-global.com), as the case may be, of CVM (www.gov.br/cvm) and B3 (www.b3.com.br),
and may be consulted by the shareholders of the Companies, in accordance with applicable regulations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34pt; text-align: justify; text-indent: -34pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>10.6</B></FONT></TD><TD STYLE="text-align: left"><U>Forward-Looking Statements and Projections</U>. This material fact presents projections, estimates,
expectations, and forward-looking statements of the Companies, including the anticipated effects of the Merger. These projections,
estimates, expectations, and forward-looking statements are largely based on current expectations, estimates of future projections, and
trends that affect or may affect the Companies&rsquo; sectors, market shares, businesses, operations, and results. While the Companies believe
that these estimates and forward-looking statements are based on reasonable assumptions, as described above, they are subject to various
risks, uncertainties, and assumptions outside the control of the Companies, including (without limitation) the risk factors described
in items 4.1 to 4.3 of the reference form of each of the Companies, and are made based on the information currently available to the Companies.
The information presented above reflects the Company&rsquo;s expectations, which are subject to risks and uncertainties, and are estimated and
indicative data that do not constitute a performance promise. These expectations depend on market conditions, the economic scenario, and
the sectors in which the Companies operate. Any change in the perception or assumptions described above may result in actual outcomes
differing from the presented projections.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Additional information regarding the matters described
in this material fact will be promptly disclosed by the Companies in accordance with applicable legislation and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">S&atilde;o Paulo, May 15, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>MARFRIG GLOBAL FOODS S.A.</B></TD>
    <TD STYLE="width: 51%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>BRF S.A.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Tang David<BR>
</B>Chief Financial Officer and Chief Investor Relations Officer</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>F&aacute;bio Luis Mendes Mariano<BR>
</B>Chief Financial and Investor Relations Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I><U>IMPORTANT NOTICE</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>This communication is not an offering document and does not constitute
an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Investors in American Depositary Shares (&ldquo;ADSs&rdquo;)
of BRF and holders of common shares of BRF are urged to read the informational document regarding the merger between BRF and Marfrig
because it will contain important information.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>U.S. holders of common shares of BRF are urged to read any
informational document or other materials prepared by BRF for common shareholders of BRF regarding the merger because they will contain
important information. BRF expects to submit copies of these documents to the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;)
when they are available, and investors and security holders may obtain free copies of these documents and other documents filed by the
Companies with the SEC at the SEC&rsquo;s website at www.sec.gov.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>A copy of any informational documents prepared for holders of
ADRs or U.S. holders of common shares of BRF (when available) may also be obtained for free from Marfrig.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>This communication contains forward-looking statements. These
statements are statements that are not historical facts and are based on the current view and estimates of management of BRF and Marfrig
of future economic circumstances, industry conditions, company performance and financial results. The words &ldquo;anticipates,&rdquo;
&ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;expects,&rdquo; &ldquo;plans&rdquo; and similar expressions, as they relate to
the Companies, are intended to identify forward-looking statements.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Statements regarding the structure and timing of any merger
between the Companies, business strategies, future synergies, future costs and future liquidity of the Companies, and pro forma results
of operations and financial condition of the Companies are examples of forward-looking statements.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Such statements reflect the current views of management and are
subject to a number of risks and uncertainties, including economic and market conditions in Brazil and globally, conditions in the industry
of the Companies, any regulatory actions relating to the merger, the ability of the Companies to achieve projected synergies and
the risk factors outlined by each of the Companies in their filings with the SEC and the Brazilian Comiss&atilde;o de Valores Mobili&aacute;rios
(CVM). There is no guarantee that the expected events, trends or results will actually occur.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Any changes in the assumptions and factors on which these forward-looking
statements are based could cause actual results to differ materially from current expectations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !< .,# 2(  A$! Q$!_\0
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M2O4-3U*TT?3+C4;Z416UNA>1SV _K7S9\0/"E[\.?%UOJVCL\=E)+YUG*/\
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M.YU;6A')>12-%9@<A5Z>9]3V]!7K(Z"BLE.2BXKJ6XINYX;^T/\ \P'ZS?\
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B1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !$ (\# 2(  A$! Q$!_\0
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MSBI4DJ.)6KV=OP?^9XF*P+BN>FM.QT=%%%?5'E!142W5NUP;=9XC,!DQAQN
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M4#Y9)&$8)^G)Q65\1_%<WB?X2:9J8MC:K=ZAL:+=NX4/CGZB@=CA-6U_Q?\
M$&]N)D2\N(81N^S6JL8X5SQP.OU/)JUX,^&6M^(=61;ZPNK/3U#&6:9"G..
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MPU:117$EO+=R8S_I,FX?D !1177CZLXM*+L10A%K5'<Q11PQK'$BQQJ,*JC
> ]A3Z**\8[ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
